You are here

  • Home
  • Archive
  • Volume 81, Issue 3
  • Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis

Article metrics

Article menu
Download PDFPDF
Epidemiology
Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis

 

Online download statistics by month:

Online download statistics by month: November 2021 to May 2023

AbstractFullPdf
Nov 202116817144
Dec 202112021185296
Jan 2022428430121
Feb 2022502508152
Mar 2022380374160
Apr 202219719780
May 202213313661
Jun 202213213528
Jul 2022959739
Aug 2022989336
Sep 2022918840
Oct 2022848232
Nov 2022727136
Dec 2022444110
Jan 2023827523
Feb 2023645413
Mar 2023373712
Apr 2023127146
May 2023172164
Total410838041193